The Hong Kong stock market's innovative drug sector rose in early trading, with Tailing Pharmaceutical (01011.HK) rising nearly 7%, Shijiazhuang Pharmaceutical Group (01093.HK) rising more than 4%, BeiGene (06160.HK), Zhaoyan Pharmaceutical (06127.HK

2025-04-29

The Hong Kong stock market's innovative drug sector rose in early trading, with Tailing Pharmaceutical (01011.HK) rising nearly 7%, Shijiazhuang Pharmaceutical Group (01093.HK) rising more than 4%, BeiGene (06160.HK), Zhaoyan Pharmaceutical (06127.HK), and WuXi Biologics (02269.HK) all rising.